Sarah A. F. Newman

Sarah A. F. Newman is Counsel in the patent litigation practice at Kirkland & Ellis LLP, focusing her efforts on defending operating companies in complex intellectual property disputes. Her practice primarily involves representing defendants, as indicated by her appearance in a significant tracked case.

Newman's experience includes handling patent infringement matters within the medical device sector. Notably, she has represented Abbott Laboratories in Miracor Medical SA v. Abbott Laboratories, a case concerning alleged infringement of patents related to left ventricular assist devices (LVADs) and systems (LVAS). This case highlights her involvement in high-stakes litigation for clients in the healthcare industry, a key area for Kirkland & Ellis's patent practice.

In the Miracor Medical SA case, her client, Abbott Laboratories, has actively pursued Inter Partes Review (IPR) petitions at the Patent Trial and Appeal Board (PTAB) for the asserted patents, leading to a partial stay of the district court proceedings. This demonstrates involvement in matters that include parallel PTAB challenges as a defensive strategy. The litigation has been consolidated with related proceedings, with the substantive claims continuing under the lead docket.

Kirkland & Ellis is recognized for its robust patent litigation capabilities, often representing clients in end-to-end, strategic disputes across various forums, including district courts, the Federal Circuit, the ITC, and the PTAB. While specific details of Sarah A. F. Newman's education and bar admissions are not reliably sourced and disambiguated from other similarly named attorneys, her role as Counsel at Kirkland & Ellis places her within a prominent patent litigation practice.